financetom
Business
financetom
/
Business
/
E.l.f. Beauty Expected to Beat Fiscal Q1 Estimates, Raise Outlook, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
E.l.f. Beauty Expected to Beat Fiscal Q1 Estimates, Raise Outlook, Oppenheimer Says
Aug 6, 2024 9:28 AM

12:13 PM EDT, 08/06/2024 (MT Newswires) -- E.l.f. Beauty (ELF) is expected to show another "beat-and-raise" quarter, building on its consistency to exceed forecasts and better share performance after result releases, Oppenheimer said in a note Tuesday.

The company's fiscal Q1 EPS is forecasted to be at least $0.95 per share, above the Wall Street view of $0.83, reflecting higher adjusted estimates due to management's strong execution, the investment firm said. The company is scheduled to report results Aug. 8.

ELF shares have recently underperformed, pulling back 18% from a mid-July high, the analysts at Oppenheimer added.

A hypothetical incremental tariff on Chinese imports, if Donald Trump is re-elected, could impact annual EPS by less than $0.50, though this is viewed as a lower probability outcome, the analysts said in the note.

Oppenheimer has a perform rating for E.l.f. Beauty.

Price: 184.75, Change: +9.10, Percent Change: +5.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
Mar 27, 2024
05:30 PM EDT, 03/27/2024 (MT Newswires) -- Merrimack Pharmaceuticals ( MACK ) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution. The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...
Keysight to launch $1.45 bln rival offer for London-listed Spirent, Sky News reports
Keysight to launch $1.45 bln rival offer for London-listed Spirent, Sky News reports
Mar 27, 2024
March 27 (Reuters) - U.S.-based Keysight Technologies ( KEYS ) is preparing to launch a formal offer for British telecommunications testing firm Spirent Communications ( SPNUF ) worth roughly 200 pence a piece, Sky News reported on Wednesday. The deal would be valued at about 1.15 billion pounds ($1.45 billion), the report added. On March 5, U.S.-listed communications equipment firm...
Cleanspark Insider Sold Shares Worth $8,466,690, According to a Recent SEC Filing
Cleanspark Insider Sold Shares Worth $8,466,690, According to a Recent SEC Filing
Mar 27, 2024
05:27 PM EDT, 03/27/2024 (MT Newswires) -- S. Matthew Schultz, Director, Executive Chairman, on March 27, 2024, sold 367,000 shares in Cleanspark ( CLSK ) for $8,466,690. Following the Form 4 filing with the SEC, Schultz has control over a total of 3,319,971 shares of the company, with 2,798,975 shares held directly and 520,996 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/827876/000095017024037353/xslF345X03/ownership.xml Price:...
Chemours fourth-quarter loss narrows on lower costs
Chemours fourth-quarter loss narrows on lower costs
Mar 27, 2024
March 27 (Reuters) - Chemours Co ( CC ) on Wednesday reported a narrower loss for the fourth quarter, helped by lower costs. The twice-delayed results come a month after the company placed its top three executives, including CEO Mark Newman, on administrative leave and said it was looking into potential material weaknesses in its financial reporting. Chemours ( CC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved